INVO Bioscience, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2025 | 0 | $0.00 | $0.00 | $0.00 |
INVO Bioscience, Inc. Earnings Date And Information
INVO Bioscience, Inc. last posted its earnings results on Monday, May 15th, 2023. The company reported $-4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.19 by $3.81. The company had revenue of 1.84 M for the quarter and had revenue of 3.02 M for the year. INVO Bioscience, Inc. has generated $-5 earnings per share over the last year ($-5.13 diluted earnings per share) and currently has a price-to-earnings ratio of -0.42. INVO Bioscience, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
INVO Bioscience, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.62 | $3.27 M | $1.84 M | ||
| 05/15/2024 | Q1 2024 | -$0.42 | $1.58 M | |||
| 04/29/2024 | Q4 2023 | -$1.27 | $1.38 M | |||
| 11/13/2023 | Q3 2023 | -$0.70 | $997,107 | $974,894 | ||
| 08/14/2023 | Q2 2023 | -$3.06 | $450,000 | $315,902 | ||
| 05/15/2023 | Q1 2023 | -$0.19 | -$4.84 | -4.65 | $348,025 | |
| 03/27/2024 | Q4 2022 | -$4.55 | $278,142 | |||
| 11/14/2022 | Q3 2022 | -$2.40 | -$4.23 | -1.83 | $200,000 | $235,321 |
| 08/15/2022 | Q2 2022 | -$4.80 | -$4.62 | 0.18 | $331,250 | $146,135 |
| 05/16/2022 | Q1 2022 | -$5.00 | -$4.73 | 0.27 | $162,598 | |
| 03/31/2022 | Q4 2021 | -$0.27 | $3.05 M | |||
| 11/15/2021 | Q3 2021 | -$4.00 | -$4.29 | -0.29 | $325,937 | $218,874 |
| 08/16/2021 | Q2 2021 | -$3.80 | -$3.48 | 0.32 | $409,344 | $208,472 |
| 05/17/2021 | Q1 2021 | -$3.60 | -$4.96 | -1.36 | $684,523 | |
| 03/30/2021 | Q4 2020 | -$15.66 | $196,572 | |||
| 11/16/2020 | Q3 2020 | -$7.15 | $336,071 | |||
| 08/13/2020 | Q2 2020 | -$5.36 | $246,072 | |||
| 05/15/2020 | Q1 2020 | -$5.86 | $258,571 | |||
| 03/30/2020 | Q4 2019 | -$3.11 | $328,572 | |||
| 11/14/2019 | Q3 2019 | -$2.92 | $303,571 |
INVO Bioscience, Inc. Earnings: Frequently Asked Questions
-
When is INVO Bioscience, Inc.'s earnings date?
INVO Bioscience, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
How can I listen to INVO Bioscience, Inc.'s earnings conference call?
The conference call for INVO Bioscience, Inc.'s latest earnings report can be listened to online.
-
How can I read INVO Bioscience, Inc.'s conference call transcript?
The conference call transcript for INVO Bioscience, Inc.'s latest earnings report can be read online.
-
How much revenue does INVO Bioscience, Inc. generate each year?
INVO Bioscience, Inc. (:INVO) has a recorded annual revenue of $3.02 M.
-
How much profit does INVO Bioscience, Inc. generate each year?
INVO Bioscience, Inc. (:INVO) has a recorded net income of $3.02 M. INVO Bioscience, Inc. has generated $-5.13 earnings per share over the last four quarters.
-
What is INVO Bioscience, Inc.'s price-to-earnings ratio?
INVO Bioscience, Inc. (:INVO) has a price-to-earnings ratio of -0.42 and price/earnings-to-growth ratio is -0.01.
